Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02405819 · ClinicalTrials.gov registry record · NA

Patient and Provider Initiated Survivorship Care Planning

A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT02405819: Completed NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

NCT02405819 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02405819, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

Objective: to describe and compare the implementation of two cancer survivorship care tools: (1) 'My Care Plan': a patient-initiated tool and (2) 'Survivorship Care Plan Builder': a provider-initiated tool. The results of this study will be used to (1) provide an initial assessment of the two survivorship care planning tools and (2) inform the design and conduct of a larger study.

Primary Outcome

As this study explores the feasibility of the survivorship care planning process, the primary outcome measure is whether or not the patient receives a complete survivorship care plan.

Interventions

  • OTHER 'My Care Plan'
  • OTHER 'Survivorship Care Plan Builder'

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2015-02
Est. Completion 2016-02
Phase NA

What the finished NCT02405819 record still lists

NCT02405819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which 'My Care Plan' is the first listed.

NCT02405819 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02405819 about?

NCT02405819 is a clinical study titled "Patient and Provider Initiated Survivorship Care Planning". Objective: to describe and compare the implementation of two cancer survivorship care tools: (1) 'My Care Plan': a patient-initiated tool and (2) 'Survivorship Care Plan Builder': a provider-initiated tool. The results of this study will be used to (1) provide an initial assessment of the two surviv...

What is the current status of trial NCT02405819?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-02. Estimated completion is 2016-02.

What interventions are being tested in trial NCT02405819?

The interventions under investigation include: 'My Care Plan' (OTHER), 'Survivorship Care Plan Builder' (OTHER).

Who is sponsoring clinical trial NCT02405819?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02405819's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02405819, the US trial registry maintained by the National Library of Medicine. NCT02405819 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.